tiprankstipranks
Trending News
More News >
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market

BioAge Labs, Inc. (BIOA) Financial Statements

Compare
99 Followers

BioAge Labs, Inc. Financial Overview

BioAge Labs, Inc.'s market cap is currently $777.85M. The company's EPS TTM is $; its P/E ratio is -2.61; BioAge Labs, Inc. is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income$ -78.19M$ -48.40M$ -39.97M
EBITDA$ -68.58M$ -55.90M$ -39.35M
Net Income$ -71.11M$ -63.85M$ -39.72M
Balance Sheet
Cash & Short-Term Investments$ 354.35M$ 21.64M$ 27.64M
Total Assets$ 358.23M$ 25.92M$ 28.43M
Total Debt$ 8.70M$ 53.25M$ 2.47M
Net Debt$ -345.64M$ 31.61M$ -25.18M
Total Liabilities$ 35.11M$ 199.32M$ 140.99M
Stockholders' Equity$ 323.13M$ -173.40M$ -112.56M
Cash Flow
Free Cash Flow$ -51.89M$ -37.53M$ -36.28M
Operating Cash Flow$ -51.52M$ -37.36M$ -36.18M
Investing Cash Flow$ -366.00K$ -266.00K$ -103.00K
Financing Cash Flow$ 381.20M$ 34.94M$ 2.50M
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

BioAge Labs, Inc. Debt to Assets

BioAge Labs, Inc. Cash Flow

BioAge Labs, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.